Skip to main content
Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.758
+0.035 (4.81%)
At close: Dec 5, 2025, 4:00 PM EST
0.735
-0.023 (-3.01%)
After-hours: Dec 5, 2025, 7:53 PM EST

Harvard Bioscience Market Cap

Harvard Bioscience has a market cap or net worth of $33.78 million as of December 5, 2025. Its market cap has decreased by -63.99% in one year.

Market Cap
33.78M
Enterprise Value
69.75M
1-Year Change
-63.99%
Ranking
#4764
Category
Nano-Cap
Stock Price
$0.76

Market Cap Chart

Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $33.78M, a decrease of -80.53%. That is a compound annual growth rate of -6.40%.

History

DateMarket Cap% Change
Dec 4, 202532.20M-65.00%
Dec 31, 202492.00M-59.72%
Dec 29, 2023228.40M97.92%
Dec 30, 2022115.40M-59.89%
Dec 31, 2021287.70M72.07%
Dec 31, 2020167.20M44.01%
Dec 31, 2019116.10M-2.11%
Dec 31, 2018118.60M3.04%
Dec 29, 2017115.10M9.83%
Dec 30, 2016104.80M-11.04%
Dec 31, 2015117.80M-35.91%
Dec 31, 2014183.80M26.15%
Dec 31, 2013145.70M15.45%
Dec 31, 2012126.20M14.42%
Dec 30, 2011110.30M-4.42%
Dec 31, 2010115.40M9.70%
Dec 31, 2009105.20M29.08%
Dec 31, 200881.50M-42.24%
Dec 31, 2007141.10M-9.96%
Dec 29, 2006156.70M15.56%
Dec 30, 2005135.60M-3.49%
Dec 31, 2004140.50M-47.56%
Dec 31, 2003267.90M170.88%
Dec 31, 200298.90M-62.67%
Dec 31, 2001264.90M52.68%
View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 908.36B
Johnson & Johnson 487.83B
AbbVie 404.22B
UnitedHealth Group 302.09B
AstraZeneca 279.81B
Novartis AG 255.73B
Merck & Co. 250.41B
Abbott Laboratories 218.05B
Market Cap Rankings